ITGAM and neoplasm: TDLNs, but not non-draining LNs, contained CD11b+ myeloid cells with higher levels of PD-L1 expression and increased numbers and activation of CD8+ T cells after anti-PD-1 therapy. Surgical resection of TDLN and inhibition of lymphocyte trafficking from LN abolished therapy induced tumour responses.